<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00640029</url>
  </required_header>
  <id_info>
    <org_study_id>P060409</org_study_id>
    <nct_id>NCT00640029</nct_id>
  </id_info>
  <brief_title>Evaluation of the Prosthetic Disc Replacement</brief_title>
  <acronym>EVA</acronym>
  <official_title>Medico-economic Evaluation of the Prosthetic Replacement of the Lumbar and Cervical Intervertebral Disc</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Until now, arthrodesis (intervertebral fusion) is the formal treatment for the lumbar and&#xD;
      cervical degenerative disc disease : arthrodesis has been the standard surgical treatment for&#xD;
      the patients when nonsurgical management has failed. However , it has shown out some&#xD;
      drawbacks : pseudoarthrosis may appear in the short term, and junctional degeneration in the&#xD;
      long term.&#xD;
&#xD;
      The replacement of the intervertebral disc by a prosthesis (arthroplasty) has been since a&#xD;
      few years a major alternative therapeutic to the arthrodesis.: it demonstrates great&#xD;
      functional results and less post-interventional complications. It is indicated to restore a&#xD;
      normal function of the spine (motion is kept)and to avoid deterioration of the adjacent&#xD;
      spinal segments over the long time.&#xD;
&#xD;
      In this clinical study, we will distinguish the cervical discal pathology and the lumbar&#xD;
      discal pathology.&#xD;
&#xD;
      The purpose of this study is to analyze the results of the arthroplasty in terms of&#xD;
      functional effects, quality of life, anatomical results and economical results.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to evaluate the cervical and lumbar intervertebral disc&#xD;
      replacement by a prosthesis ( arthroplasty ) in adults suffering from degenerative disc&#xD;
      disease.&#xD;
&#xD;
      For the cervical pathology, a comparative randomized multi-site study of the medico-economic&#xD;
      evaluation of the prosthesis implementation versus arthrodesis, the standard treatment, will&#xD;
      be realised , for patients from 20 to 55 years old, within very rigorous exclusion and&#xD;
      inclusion criteria.&#xD;
&#xD;
      For the lumbar pathology, a comparative randomized multi-site study of the medico-economic&#xD;
      evaluation of the prosthesis implementation versus arthrodesis, the standard treatment, will&#xD;
      be realized , for patients from 50 to 65 years old, within acute exclusion and inclusion&#xD;
      criteria.&#xD;
&#xD;
      For patients under 50 years old, randomization is not used as arthroplasty offers very good&#xD;
      results. By these young patients, a cohort study will thus be realized.&#xD;
&#xD;
      Patients with degenerative discal disease at one or more levels will be recruited in 17 sites&#xD;
      in France :&#xD;
&#xD;
        -  3 sites in ASSITANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)&#xD;
&#xD;
        -  14 sites in France outside AP-HP.&#xD;
&#xD;
      The study will have 3 parts :&#xD;
&#xD;
        -  Cervical pathology : 500 patients divided on 250 arthroplasties and 250 arthrodeses.&#xD;
&#xD;
        -  Lumbar pathology : 525 patients divided according to their age:&#xD;
&#xD;
        -  over 50 years old : randomization in 175 lumbar arthroplasties and 175 lumbar&#xD;
           arthrodeses.&#xD;
&#xD;
        -  until 50 years old : cohort study : 175 lumbar arthroplasties.&#xD;
&#xD;
      This study will last 3 years : a 2 year-period of inclusion , and a post interventional one&#xD;
      year-follow-up period for each included patient.&#xD;
&#xD;
      The duration of the participation in the study for each patient is one year.&#xD;
&#xD;
      7 evaluations will be realized for each patient : pre-interventional visit, intervention,&#xD;
      post-interventional visit, visit at 45 days, visit at 3 months, visit at 6 months and visit&#xD;
      at one year.&#xD;
&#xD;
      Each visit will comprise different exams and observations.&#xD;
&#xD;
      The criterion of principle judgement will be the quality of life measured as follows :&#xD;
&#xD;
        -  For the lumbar pathology, the Oswestry Low Back Pain Disability Questionnaire, the SF36&#xD;
           Questionnaire, the Visual Analog Scale (Pain), at each visit.&#xD;
&#xD;
        -  For the cervical pathology : the NDI score, the SF36 Questionnaire, the Visual Analog&#xD;
           Scale (Pain), at each visit.&#xD;
&#xD;
      The secondary criteria will be medico-economical and clinical too. Arthrodesis and&#xD;
      Arthroplasty will be compared in terms of:&#xD;
&#xD;
        -  anatomical results of the intervention&#xD;
&#xD;
        -  intervention tolerance&#xD;
&#xD;
        -  wear (estimated by the discal height)&#xD;
&#xD;
        -  costs of the intervention.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Insuffisent recruitment&#xD;
  </why_stopped>
  <start_date>February 2008</start_date>
  <completion_date type="Actual">February 2011</completion_date>
  <primary_completion_date type="Actual">February 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Patient satisfaction at one year. Oswestry questionnaire (lumbar pathology) or NDI questionnaire (cervical pathology), SF36 score and Visual Analog Scale (Pain</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction at post-interventional visit, after 45 days, at 3 months, and at 6 months</measure>
    <time_frame>post-interventional visit, after 45 days, at 3 months, at 6 months and 1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost of the treatments</measure>
    <time_frame>post-interventional visit, after 45 days, at 3 months, at 6 months and 1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tolerance of the intervention, stability of the prosthesis</measure>
    <time_frame>post-interventional visit, after 45 days, at 3 months, at 6 months and 1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">301</enrollment>
  <condition>Lumbar Degenerative Disc Disease</condition>
  <condition>Cervical Degenerative Disc Disease</condition>
  <condition>Kyphosis</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cervical - Arthroplasty</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cervical - Arthrodesis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lumbar - Over 50 years - Arthroplasty</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Lumbar - Over 50 years - Arthrodesis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>5</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lumbar - Under 50 years - Arthroplasty</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Arthrodesis</intervention_name>
    <description>posterior,&#xD;
anterior,&#xD;
circumference approach</description>
    <arm_group_label>2</arm_group_label>
    <arm_group_label>4</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Arthroplasty (PRODISC-C® , PRODISC-L®, Mobi-C®, Mobidisc®, PrestigeLP®, A-Mav®, O-Mav®, DISCOCERV®)</intervention_name>
    <description>SYNTHES : PRODISC-C® , PRODISC-L®&#xD;
LDR : Mobi-C®, Mobidisc®&#xD;
MEDTRONIC : PrestigeLP®, A-Mav®, O-Mav®&#xD;
SCIENT'X : DISCOCERV®</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>3</arm_group_label>
    <arm_group_label>5</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  cervical disc:&#xD;
&#xD;
               -  20 to 55 years old;&#xD;
&#xD;
               -  symptomatic disc disease between C3-C7 defined as:&#xD;
&#xD;
               -  Cervical or brachial(radicular) pain and/or functional/neurologic deficit with at&#xD;
                  least one of the following conditions confirmed by imaging :&#xD;
&#xD;
               -  Hernia of the gelatinous core;&#xD;
&#xD;
               -  Spondylosis (osteophytes); loss of height of the disc;&#xD;
&#xD;
               -  Not reacting to the no-invasive treatment or progressive symptoms or compressions&#xD;
                  ;&#xD;
&#xD;
               -  NDI &gt;= 15/50;&#xD;
&#xD;
               -  Ready to respect the instructions;&#xD;
&#xD;
               -  More than one vertebral level requiring a treatment;&#xD;
&#xD;
               -  At a vertebral block close to the level to be treated;&#xD;
&#xD;
               -  Associated to a fusion at the adjacent level or another level;&#xD;
&#xD;
               -  Written assent;&#xD;
&#xD;
               -  Patient who can receive one or other treatment;&#xD;
&#xD;
          -  lumbar disc:&#xD;
&#xD;
               -  25 to 65 years;&#xD;
&#xD;
               -  Symptomatology of prevalent lumbago with or without radiculalgia and failure of&#xD;
                  the medical treatments;&#xD;
&#xD;
               -  Idiopathic discopathies or after cure of disc herniations (except prior&#xD;
                  infections);&#xD;
&#xD;
               -  Repetition of disc herniation (except excluded hernia);&#xD;
&#xD;
               -  Discopathies with median posterior disc herniation with limited development and&#xD;
                  loss of discal height;&#xD;
&#xD;
               -  1 or 2 contiguous stages or not among L3L4, L4L5, L5S1;&#xD;
&#xD;
               -  Written assent;&#xD;
&#xD;
               -  Patient who can receive one or other treatment;&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  cervical disc:&#xD;
&#xD;
               -  Cervical instability: in flexion/extension Translation &gt; 3 mm and /or &gt;11 degrees&#xD;
                  of rotary difference with one or the other adjacent level;&#xD;
&#xD;
               -  Serious problem of articular facet or degeneration.;&#xD;
&#xD;
               -  Known allergy to cobalt, chromium plates, molybdenum, titanium or polyethylene;&#xD;
&#xD;
               -  Clinically compromised vertebrae at level (s) touched after a current or passed&#xD;
                  traumatism;&#xD;
&#xD;
               -  Serious spondylosis (MESOCEPHALES osteophytes; loss height of the disc&gt;70% or&#xD;
                  Absence of motion(&lt; 2°));&#xD;
&#xD;
               -  Osteoporosis(DEXA);&#xD;
&#xD;
               -  Paget, osteomalacia or metabolic osseous disturbs ;&#xD;
&#xD;
               -  Serious Willis disease asking an insulin management;&#xD;
&#xD;
               -  Pregnancy;&#xD;
&#xD;
               -  Active, local or generalized infection;&#xD;
&#xD;
               -  Taking treatments or drugs which one knows that they interfere on the management&#xD;
                  of the bone/ the soft part (e.g. steroids);&#xD;
&#xD;
               -  Rheumatoid arthritis or another disease car-immune;&#xD;
&#xD;
               -  Systemic disease (AIDS, HIV, hepatitis);&#xD;
&#xD;
               -  Active malignity compromising the vital forecast at the short term;&#xD;
&#xD;
               -  Septic antecedents;&#xD;
&#xD;
               -  No-affiliation with the Social Security;&#xD;
&#xD;
               -  Patient refusing to be recontacted by mail or telephone apart from the visits;&#xD;
&#xD;
               -  Patient refusing the randomization;&#xD;
&#xD;
          -  lumbar disc:&#xD;
&#xD;
               -  Morbid Obesity;&#xD;
&#xD;
               -  Abdomen multi operated;&#xD;
&#xD;
               -  Crowned slope L5-S1 high;&#xD;
&#xD;
               -  Traumatic after-effects with moderate deformations of the vertebra ;&#xD;
&#xD;
               -  Symptomatic lumbar canal stenosis;&#xD;
&#xD;
               -  Septic antecedents of the site to be operated;&#xD;
&#xD;
               -  Great degenerative or constitutional vertebral instability ;&#xD;
&#xD;
               -  Narrow lumbar channel and/or excluded and migrated lumbar slipped disc;&#xD;
&#xD;
               -  Scoliosis &gt;8;&#xD;
&#xD;
               -  Advanced articular osteoarthritis;&#xD;
&#xD;
               -  Severe osteoporosis ;&#xD;
&#xD;
               -  Disease of Paget, Osteomalacia, disturb metabolic osseous;&#xD;
&#xD;
               -  Disease car-immune rheumatoid;&#xD;
&#xD;
               -  Pregnancy;&#xD;
&#xD;
               -  Badly balanced diabetes ;&#xD;
&#xD;
               -  Systemic disease;&#xD;
&#xD;
               -  Vascular Problem (arteritis lower limb, aortic aneurism);&#xD;
&#xD;
               -  Evolutionary Hepatitis ;&#xD;
&#xD;
               -  Immunodeficient Disease (of which HIV);&#xD;
&#xD;
               -  No-affiliation with the Social Security;&#xD;
&#xD;
               -  Patient refusing to be recontacted by mail or telephone apart from the visits;&#xD;
&#xD;
               -  Patient refusing the randomization;&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philippe Cottin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jacques BRUNON, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Saint-Etienne's Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Service de Chirurgie CHU Hopital Antoine Béclère</name>
      <address>
        <city>Clamart</city>
        <zip>92140</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de Neurochirurgie CHU Saint-Etienne</name>
      <address>
        <city>Saint-etienne</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <study_first_submitted>February 15, 2008</study_first_submitted>
  <study_first_submitted_qc>March 19, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 20, 2008</study_first_posted>
  <last_update_submitted>March 6, 2015</last_update_submitted>
  <last_update_submitted_qc>March 6, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 10, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Arthroplasty</keyword>
  <keyword>Arthrodesis</keyword>
  <keyword>Prosthesis</keyword>
  <keyword>Disc replacement</keyword>
  <keyword>Spine</keyword>
  <keyword>Lumbar</keyword>
  <keyword>Cervical</keyword>
  <keyword>Intervertebral disk</keyword>
  <keyword>Cervical or lumbar intervertebral disk</keyword>
  <keyword>Degenerative pathology</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Diseases</mesh_term>
    <mesh_term>Intervertebral Disc Degeneration</mesh_term>
    <mesh_term>Kyphosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Meloxicam</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

